Compare PCVX & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | OHI |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | 69 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 13.2B |
| IPO Year | 2020 | 2001 |
| Metric | PCVX | OHI |
|---|---|---|
| Price | $52.99 | $44.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $98.33 | $46.60 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.02% |
| EPS Growth | N/A | ★ 25.16 |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $1,190,099,000.00 |
| Revenue This Year | N/A | $4.87 |
| Revenue Next Year | N/A | $5.45 |
| P/E Ratio | ★ N/A | $22.95 |
| Revenue Growth | N/A | ★ 13.19 |
| 52 Week Low | $28.09 | $35.04 |
| 52 Week High | $65.00 | $49.14 |
| Indicator | PCVX | OHI |
|---|---|---|
| Relative Strength Index (RSI) | 40.51 | 33.80 |
| Support Level | $51.34 | $42.98 |
| Resistance Level | $56.04 | $45.26 |
| Average True Range (ATR) | 2.23 | 0.93 |
| MACD | -0.46 | -0.43 |
| Stochastic Oscillator | 0.15 | 5.29 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.